CASI Pharmaceuticals
CASI
#8916
Rank
HK$0.64 B
Marketcap
HK$41.49
Share price
-3.96%
Change (1 day)
18.98%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -HK$0.22 Billion

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are HK$23.1 Million. In 2023 the company made an earning of -HK$0.21 Billion, an increase over its 2022 earnings that were of -HK$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.22 Billion2.51%
2023 -HK$0.21 Billion-29.55%
2022 -HK$0.3 Billion4.43%
2021 -HK$0.28 Billion-24.56%
2020 -HK$0.37 Billion4.74%
2019 -HK$0.36 Billion65.13%
2018 -HK$0.22 Billion155.07%
2017 -HK$83.85 Million13.93%
2016 -HK$73.6 Million31.18%
2015 -HK$56.11 Million-72.5%
2014 -HK$0.21 Billion356.62%
2013 -HK$44.68 Million-60.55%
2012 -HK$0.12 Billion218.41%
2011 -HK$35.57 Million0.74%
2010 -HK$35.31 Million-32.54%
2009 -HK$52.33 Million-66.98%
2008 -HK$0.16 Billion-14.22%
2007 -HK$0.19 Billion7.04%
2006 -HK$0.18 Billion27.95%
2005 -HK$0.14 Billion4.51%
2004 -HK$0.13 Billion-15.84%
2003 -HK$0.16 Billion-55.29%
2002 -HK$0.35 Billion-34.05%
2001 -HK$0.53 Billion31.73%
2000 -HK$0.4 Billion31.56%
1999 -HK$0.31 Billion145.56%
1998 -HK$0.13 Billion76.4%
1997 -HK$69.29 Million36.92%
1996 -HK$50.61 Million